North American Cardiac Ablation Market size is projected to cross USD 3.5 billion by 2028, according to a latest forecast report by Graphical Research.
Growing prevalence of several cardiovascular disorders in North America will positively influence the market growth. For instance, as per the Centers for Disease Control and Prevention, in 2017, approximately 18.2 million Americans were affected by coronary heart disease. The growth is primarily owing to adoption of sedentary lifestyle, excessive consumption of tobacco and smoking habits, increasing patient pool with diabetes mellitus, obesity and high intake of alcohol among population. Moreover, increasing number of tachycardia cases in the region will proliferate demand for cardiac ablation procedures. Further, increasing awareness regarding advanced cardiac treatments coupled with expanding sophisticated infrastructure will fuel the industry growth.
Continuous technological advancements in cardiac ablation devices in recent years will strengthen overall the market demand. Strong presence of key companies for development of technologically advanced cardiac ablation devices. Further, introduction of innovative radiofrequency ablators for minimally invasive cardiac procedures with enhanced accuracy and affordable cost is anticipated to enhance the demand for cardiac ablation procedures in the region. For instance, in January 2021, Medtronic plc has received approval for its DiamondTemp ablation system by U.S. Food and Drug Administration (FDA) in U.S. for the treatment of symptomatic paroxysmal atrial fibrillation for patient suffering from atrial fibrillation. Moreover, rising patient preference towards minimally invasive treatments will accelerate the industry growth.
The COVID-19 pandemic has negatively impacted the overall North America cardiac ablation industry. Owing to temporary ban of elective procedures in clinical settings, imposition of preventive lockdown in several nations, disrupted supply chain and logistics. Moreover, patient reluctance to visit clinical facilities affected the industry size. However, rising incidence of numerous heart diseases and growing awareness among population regarding ablation procedures.
The electrical ablators segment will witness 14.7% CAGR during the forcast timeframe. Electrical ablators offer several benefits in cardiac ablation procedures including enhanced accuracy and survival rate and reduced procedural time thereby. High usage of electrical ablators in cardiac procedure will augment the market revenue. Additionally, continuous development of advanced technology enabled devices for better patient outcome will impel market expansion.
The surgical segment accounted for more than USD 353 million revenue in 2021. High adoption of surgical ablation procedures to treat patients with atrial fibrillation for rhythm control will fuel the market share. Moreover, numerous minimally invasive modalities are developed for surgical cardiac ablation including mini-thoracotomy, off-bypass thoracostomy and video-assisted thoracoscopic surgery.
Browse detailed statistical insights from the report, “North America Cardiac Ablation Market Forecast 2028 By End-use (Hospitals, Ambulatory Surgical Centers, Cardiac Centers), By Product (Radiofrequency (RF) Ablators, Electrical Ablators, Cryoablation Devices, Ultrasound Ablators), By Approach (Catheter-based, Open/surgical), By Application (Atrial Fibrillation & Flutter, Tachycardia), Research Report, Country Outlook (U.S., Canada), COVID-19 Impact Statistics, Country Outlook, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share” along with the table of contents (ToC) @
The tachycardia segment held over 9% market share in 2021. Growing patient pool of tachycardia in the region owing to high alcohol consumption, stress, hypertension, overweight & obesity, unhealthy diet and hyperthyroidism. Furthermore, growing adoption of cardiac ablation procedures to control heartbeats and related complications among cardiac patients will impel market growth. Cardiac ablation procedures are used to limit morbidity as well as enhance the survival rate of critical patient.
The cardiac centers segment was valued over USD 290 million revenue in 2021 attributed to developed sophisticated healthcare infrastructure and high healthcare expenditure in the region. Moreover, high accessibility and availability of skilled healthcare professionals and accessibility of advanced instruments in the healthcare settings will stimulate customer preference towards cardiac centers for critical care.
Canada cardiac ablation industry will exhibit a CAGR of 14.3% during forecasted timeline due to surge in healthcare expenditure. in 2019, Canada spent around 11.5% of the total GDP on healthcare sector. Moreover, favorable demographics such as growing number of baby boomers, rising prevalence of cardiac diseases, adoption of advanced technologies will fuel the market value.
The North American cardiac ablation market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2017 to 2028, for the following segments:
North America Market, By Product
- Radiofrequency (RF) ablators
- Electrical ablators
- Cryoablation devices
- Ultrasound ablators
North America Market, By Approach
North America Market, By Application
- Atrial fibrillation & flutter
North America Market, By End-use
- Ambulatory surgical centers
- Cardiac centers
The above information has been provided for the following countries: